国产精品99一区二区三_免费中文日韩_国产在线精品一区二区_日本成人手机在线

China to promote standardized overall treatment for breast cancer

Source: Xinhua| 2019-03-30 17:24:31|Editor: Yurou
Video PlayerClose

BEIJING, March 30 (Xinhua) -- China is moving to promote a package of breast cancer prevention and treatment standards across the country, hoping to further prolong patients' survival time and narrow the diagnosis and treatment gap between urban and rural areas.

A series of guidelines covering breast cancer screening, early diagnosis and treatment and rational drug use to follow-up treatment and management of concomitant diseases were released Saturday at an ongoing cancer and health conference, which was jointly held by the National Cancer Center (NCC), Cancer Foundation of China and Beijing Breast Disease Society.

Data released by the NCC in March 2018 showed that the mortality rate of breast cancer in China accounted for 16.5 percent of all female cancers. As breast cancer continues to lay claim to top incidence rates both at home and abroad, its cure rate has been improving steadily in China, with the five-year survival rate reaching 83.2 percent between 2010 and 2014, up by 7.3 percent in 10 years.

As survival time has been significantly prolonged, more patients have entered a chronic disease period, according to the guidelines for breast cancer follow-up and overall management of concomitant diseases, the first of its kind in China, by the NCC.

Common concomitant diseases of breast cancer include cardiovascular diseases, abnormal bone metabolism and depression. "Among elder patients, cardiovascular diseases have caused even more deaths than cancer itself," said Ma Fei, executive chairman of the conference and expert from the NCC.

Under the dual effects of ovarian dysfunction and drugs, postmenopausal patients suffer a distinct drop in estrogen levels, which often results in an abnormal lipid amount in the blood and increases the risk of cardiovascular diseases, Ma explained.

In addition, a large number of patients will keep receiving endocrine therapy for five to 10 years after cancer treatment, which is often accompanied by abnormal bone metabolism, osteoporosis and even fractures.

The guidelines clearly require doctors, through interdisciplinary collaborations, to take into consideration a patient's blood lipid level and bone density before giving endocrine therapy. It also suggests that doctors intervene to help patients quit smoking and drinking alcohol as well as avoid tumbles and serious body impacts according to the evaluation of their overall health conditions.

Xu Binghe, a professor at the NCC who has been focusing on breast cancer treatment for more than three decades, noted that the guidelines, by standardizing the follow-up visits and examinations, would bring the prevention of possible concomitant diseases earlier than before and extend the health care to the survivors' entire lifetime.

"It will certainly assist the patients in returning to their family and society in a better state," Xu said.

Ma Fei regarded the guidelines as an important step to change the disease-centered diagnosis and treatment model into a patient-centered one. "The patients should not only live longer but also live well," he said.

TOP STORIES
EDITOR’S CHOICE
MOST VIEWED
EXPLORE XINHUANET
010020070750000000000000011100001379364281
主站蜘蛛池模板: 青岛市| 开原市| 柳林县| 阿勒泰市| 龙山县| 墨玉县| 通江县| 株洲县| 信宜市| 林甸县| 鸡东县| 湘乡市| 德昌县| 额济纳旗| 内江市| 遵化市| 穆棱市| 顺昌县| 什邡市| 灵武市| 共和县| 陵川县| 潞城市| 珲春市| 临清市| 云南省| 平武县| 潍坊市| 湖州市| 高邮市| 龙井市| 保山市| 尤溪县| 东港市| 永胜县| 扶余县| 夹江县| 望都县| 宜城市| 肃北| 东阳市|